Acadia Healthcare (NASDAQ: ACHC) traded 5.74 million shares in its latest session, significantly above its average volume of 2.8 million. The Medical Care Facilities company, operating in the Healthcare sector, reached an intraday high of $20.63 and a low of $18.32.
Over the past 52 weeks, ACHC has traded between $17.12 and $47.08, reflecting substantial volatility. The stock currently carries a 1-year price target of $27.50 and a beta of 0.89, suggesting slightly lower volatility than the broader market.
Price Performance and Earnings
ACHC has faced short-term pressure with a -7.06% drop over the past week and a -20.86% decline over the past month. Despite these setbacks, the stock recorded a 5.30% gain over three months, although it fell -16.35% over six months.
Over the last year, ACHC lost -48.90%, and it has fallen -52.14% year-to-date. The trailing 12-month EPS is $1.18, while next year’s EPS is estimated at $2.52, with next quarter EPS projected at $0.52. This implies an EPS growth rate of -26.70% for this year and 4.08% for next year. Analysts project a -6.06% annual EPS decline over the next five years, compared to 17.49% annual growth over the past five years.
Float and Short Interest
Acadia Healthcare has 92.35 million shares outstanding and a float of 90.63 million. Short interest as of October 15, 2025 was 12.1 million shares, indicating moderate bearish sentiment.
Leadership includes Christopher Howal Hunter as CEO & Director and Dr. Nasser Khan M.D. as Chief Operating Officer, guiding the company’s operational strategy.
Recent Financial Overview
For the fiscal quarter ending June 30, 2025, ACHC reported revenue of $869.23 million and an operating income of $142.30 million. EBITDA was $191.30 million, while diluted EPS came in at $0.33, reflecting operational profitability despite recent market headwinds.
Analysts’ Ratings and Price Targets
Among 8 analysts covering the stock, 5 recommend BUY, 1 recommends SELL, 1 rates HOLD, and 1 gives an OVERWEIGHT rating.
Analysts have set a high price target of $38.00 and a low target of $17.00, resulting in an average 12-month price target of $27.68. Based on these targets, ACHC could rise 87.56% to the high target or fall -16.09% to the low target. Achieving the average target would imply a 36.62% gain from current levels.
EPS: Estimates vs. Actual
Yearly EPS estimates for ACHC range between $3.36 and $3.42, averaging $3.38. The prior quarter reported a positive EPS surprise of $0.71. Next quarter EPS estimates range from $0.35 to $0.54, with an average of $0.44, suggesting potential for continued earnings growth.
Overall, Acadia Healthcare (NASDAQ: ACHC) presents a mixed picture — recent price declines contrast with strong analyst projections and steady earnings. Investors may find the stock attractive for potential upside while monitoring sector volatility and EPS growth trends.